AzTrials
AzTrials

Motility FunctionEMAPNCT02661386

Esophageal Manometry During Recovery From Anesthesia: Pilot Study

A study testing Motility Procedure in people with Motility Function, run by University of California, San Francisco at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

1. An intact pharyngoesophageal reflex is essential to protect the upper airway from aspiration of either mouth contents or regurgitated gastric refluxate. This reflex is essential at protecting the airway in all patients. 2. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Motility Function
What is being tested?
Motility Procedure
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteUnited States
Study dates
Jan 2016to 5 Mar 2019
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients between 18 and 70 years of age (ASA I or II).
  • Already scheduled for routine general anesthetic procedure requiring an endotracheal tube for anesthesia administration.
  • Scheduled abdominal surgical procedure including endoscopy, colonoscopy, ERCP, cholecystectomy, appendectomy, colectomy or small bowel resection.
  • Willing and able to give informed consent in either English or Spanish.

Who cannot join

  • Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study.
  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
  • Patients not meeting entry criteria above.
  • Refusal to give informed consent.
  • Coagulopathy (INR > 2 and/or platelet count < 100,000.
  • White Blood Cell count < 5,000/mm3
Show all 11Show fewer
  • Arrhythmia
  • Serum creatinine > 2 mg/dl
  • Prior known or suspected nasal obstruction.
  • Known or suspected Zenker's diverticulum of esophagus, esophageal stricture, head/neck radiation therapy, hereditary telangiectasis, esophageal varices, cirrhosis.
  • Anticoagulant usage such as heparin or Plavix

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Zuckerberg San Francisco General Hospital

    San Francisco, California, 94110

Other trials in United States

About this study

  1. An intact pharyngoesophageal reflex is essential to protect the upper airway from aspiration of either mouth contents or regurgitated gastric refluxate. This reflex is essential at protecting the airway in all patients.
  2. In patients, while under general anesthesia, it is postulated that an identifiable upper esophageal sphincter and esophageal peristalsis are not present.
  3. With the cessation of general anesthetics, accompanied by the reversal of nerve block, normal pharyngoesophageal peristaltic activity correlates with awakening the patient from anesthesia. This would be identified by the performance of esophageal manometry.
  4. A return of normal verbally stimulated pharyngoesophageal swallowing sequence accurately identifies a safe time to remove endotracheal tubes and/or reverse anesthesia. This verbally stimulated swallowing sequence correlated precisely with the return of objective pharyngoesophageal function.
Read the detailed description

This pilot study will examine esophageal manometry in patients emerging from routine general anesthesia. Manometry of the esophagus is not a standard part of surgery or general anesthesia. The investigators will be using standard solid state high resolution manometry. One of the authors (JPC) evaluates all routine manometry for patients undergoing such procedures at both UCSF and SFGH. The use of manometry in patients recovering from anesthesia will permit the investigators to assess the recovery of a normal swallowing mechanism. An adequate determination of return of normal swallowing sequence is likely to determine the safe time for extubation. The investigators propose to, as a research study, investigate esophageal motor function using standard high resolution esophageal manometry in 10 patients recovering from general anesthesia. These studies are likely to document that the return of normal pharyngoesophageal function will coordinate with verbal commands to initiate swallowing. This pilot study will help clarify the precise timing of the return of normal function in the oropharynx and the proximal esophagus and thus determine the safe time for removal of the endotracheal or nasotracheal intubation.

Being tested
Motility Procedure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motility ProcedureDevice

    The use of esophageal manometry device during general anesthesia

Study groups in NCT02661386
Study groupRoleWhat they receive
Manometry DeviceOtherDuring the last 10 minutes of subjects "waking up" from anesthesia, the motility procedure will be performed.
Receives: Device: Motility Procedure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total Time of the Return of Normal Pharyngoesophageal Function

    Our primary objective is to determine the timing of the return of normal pharyngoesophageal function upon withdrawal of general anesthesia.

    Measured: From withdrawal of general anesthesia until the return of normal pharyngoesophageal function, assessed up to 40 minutes.

Secondary outcomes (1)
  1. Number of Participants With Normal Pharyngoesophageal Function.

    Correlation of the return of normal pharyngoesophageal function with other markers generally used by Anesthesia staff to indicate a safe time for removal of endotracheal tubes.

    Measured: From withdrawal of general anesthesia until the return of normal pharyngoesophageal function, assessed up to 40 minutes.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2016 (estimated)
  2. Study startJan 2016
  3. Primary completion5 Mar 2019
  4. Study completion5 Mar 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02661386
Sponsor's protocol ID
14-15466
Acronym
EMAP
Status last verified
Jul 2026
First submitted
19 Jan 2016
Last updated
20 Aug 2026
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Motility Procedure in people with Motility Function, run by University of California, San Francisco at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 20 Aug 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total Time of the Return of Normal Pharyngoesophageal Function (time frame: From withdrawal of general anesthesia until the return of normal pharyngoesophageal function, assessed up to 40 minutes.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in